Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways
- 31 October 2004
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 18 (5) , 1039-1057
- https://doi.org/10.1016/j.hoc.2004.06.007
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- IL‐1β mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesisThe FASEB Journal, 2003
- Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted AgentsJournal of Clinical Oncology, 2003
- HIF‐1α protein as a target for S‐nitrosationFEBS Letters, 2003
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in MiceScience, 2001
- Induction of Hypoxia-Inducible-Factor 1 by Nitric Oxide Is Mediated via the PI 3K PathwayBiochemical and Biophysical Research Communications, 2000
- TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapyEuropean Journal Of Cancer, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971